Mosaic display of stable hemagglutinin monomers induces broad immune responses
Kim, H.; Min, S. C.; Lee, D. B.; Jeong, J. H.; Kim, E. J.; Maeng, J. Y.; Seok, J. H.; Lee, J.-H.; Jang, Y.; Jang, U. S.; Ysenbaert, T.; Catani, J. P. P.; Lee, J.; Lee, Y.; Kim, Y. K.; Lee, G.; Mun, J. Y.; Jun, H. S.; Baek, Y. H.; Saelens, X.; Lee, J.; Chung, M. S.; Song, M.-S.; Kim, K. H.
Show abstract
The nature of the interplay between immunity and viral variation is infinitely adaptive. Infection frequently induces immune responses against variation-prone epitopes, rather than against spatially hidden conserved epitopes. It thus remains a substantial challenge to elicit the immune responses to the conserved epitopes providing broad-spectrum immunity. We developed an approach of scaffold-mediated mosaic display to present monomeric influenza virus hemagglutinins (HAs), which exposes highly conserved stem and interface epitopes. Stable monomers were rationally engineered from H1 and H3 subtypes and B type HA trimers, with amino acid mutations at the monomer-monomer interface and for disulfide bond formation, and fused to a self-assembling scaffold, to generate a mosaic HA monomer-displaying nanoparticle, 3HA-np. Immunization with 3HA-np induced broadly neutralizing antibodies (bnAbs) in mice and ferrets and protected against challenges with H1N1 and H3N2 viruses. Competitive immunoassays revealed that 3HA-np induced high interface- and stem-binding Ab titers as compared to head Ab titers, indicating that the monomeric and mosaic nature of 3HA-np elicit cross-reactive Abs. Our results suggest that exposure of the hidden conserved epitope by monomer-displaying nanoparticles is a promising approach to generate a universal influenza vaccine.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Single-dose avian influenza A(H5N1) Clade 2.3.4.4b hemagglutinin-Matrix-M nanoparticle vaccine induces neutralizing responses in nonhuman primates 97%
- A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses 96%
- Ending transmission of SARS-CoV-2: sterilizing immunity using an intranasal subunit vaccine 95%
Similar papers in this journal
- Heterologous Prime-Boost with Immunologically Orthogonal Protein Nanoparticles for Peptide Immunofocusing 96%
- SARS-CoV-2 B Epitope-Guided Neoantigen NanoVaccines Enhance Tumor-Specific CD4/CD8 T Cell Immunity Through B Cell Antigen Presentation 95%
- Genetically engineered MRI-trackable extracellular vesicles as SARS-CoV-2 mimetics for mapping ACE2 binding in vivo 94%
Similar papers in this journal
- Sustained vaccine exposure elicits more rapid, consistent, and broad humoral immune responses to multivalent influenza vaccines 93%
- TSHR-targeting nucleic acid aptamer treats Graves' ophthalmopathy via novel allosteric inhibition 93%
- Massively parallel screening of TIR-derived peptides reveals vast TLR-targeting immunomodulatory peptides 93%
Similar papers in this journal
- In vivo mRNA delivery to virus-specific T cells by light-induced ligand exchange of MHC class I antigen-presenting nanoparticles 94%
- Multivariate mining of an alpaca immune repertoire identifies potent cross-neutralising SARS-CoV-2 nanobodies 93%
- Preclinical evaluation of a SARS-CoV-2 mRNA vaccine PTX-COVID19-B 93%
Similar papers in this journal
- Role of nanoscale antigen organization on B-cell activation probed using DNA origami 93%
- Determination of oligomeric organization of membrane proteins from native membranes at nanoscale-spatial and single-molecule resolution 92%
- Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.